HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region.

Abstract
Expression of IL-18 in intestinal epithelial cells (IEC) has been implicated in Th1 cell-mediated chronic intestinal inflammation and anti-tumor immunity. However, physiological regulatory factors have not been identified. Besides their effects on proliferation and restitution, immunomodulatory functions have been attributed to short chain fatty acids (SCFA). We investigated the effect of SCFA (butyrate, propionate, acetate) on expression of IL-18 in IEC in vitro and in vivo. Expression of IL-18 mRNA and protein in human carcinoma-derived HT-29 and Caco-2 cells was analyzed by reverse transcription-PCR and Western blot. Transcriptional regulation of IL-18 gene expression was determined by transient transfection of wild-type and mutated IL-18 promoter. Further, in vivo expression of IL-18 in the intestine from butyrate-treated and untreated mice was assessed by immunohistochemistry. IL-18 mRNA and the IL-18 protein were expressed in IEC, while IL-18 secretion was not observed. Butyrate and acetate increased intracellular IL-18 content in a time- and dose-dependent fashion. In contrast to proinflammatory stimuli butyrate potently activated the IL-18 promoter, indicating that IL-18 is regulated at the transcriptional level by SCFA. Furthermore, a 108-bp sequence in the proximal region was identified to be essential for IL-18 promoter activation by butyrate. As proof of principle butyrate effects were confirmed in vivo by demonstration of increased IL-18 protein expression in IEC from butyrate-treated mice. In conclusion, SCFA up-regulate IL-18 protein expression in IEC, suggesting a potential regulatory contribution of these luminal constituents to T cell mediated inflammatory and neoplastic intestinal conditions.
AuthorsUwe Kalina, Noriko Koyama, Tomoko Hosoda, Heike Nuernberger, Kazuto Sato, Dieter Hoelzer, Frank Herweck, Tobias Manigold, Manfred V Singer, Siegbert Rossol, Ulrich Böcker
JournalEuropean journal of immunology (Eur J Immunol) Vol. 32 Issue 9 Pg. 2635-43 (Sep 2002) ISSN: 0014-2980 [Print] Germany
PMID12207348 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Butyrates
  • Interleukin-18
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
Topics
  • Acetates (pharmacology)
  • Adenocarcinoma (pathology)
  • Animals
  • Butyrates (pharmacology)
  • Colonic Neoplasms (pathology)
  • Dose-Response Relationship, Drug
  • Epithelial Cells (drug effects, metabolism)
  • Gene Expression Regulation (drug effects)
  • Humans
  • Interleukin-18 (biosynthesis, genetics)
  • Intestinal Mucosa (drug effects, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Neoplasm Proteins (biosynthesis, genetics)
  • Promoter Regions, Genetic (drug effects)
  • RNA, Messenger (biosynthesis)
  • RNA, Neoplasm (biosynthesis)
  • Regulatory Sequences, Nucleic Acid
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription, Genetic (drug effects)
  • Transfection
  • Tumor Cells, Cultured (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: